Terms: = Ovarian cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
54 results:
1. ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
2. A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany.
van der Ven J; Linz VC; Anic K; Schmidt MW; Loewe A; Krajnak S; Schmidt M; Kommoss S; Schmalfeldt B; Sehouli J; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2023 Aug; 308(2):527-534. PubMed ID: 36707423
[TBL] [Abstract] [Full Text] [Related]
3. Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer?
Diniz TP; Menezes JN; Goncalves BT; Faloppa CC; Mantoan H; Kumagai LY; Badiglian-Filho L; Bovolim G; Guimaraes APG; De Brot L; Baiocchi G
Gynecol Oncol; 2023 Feb; 169():131-136. PubMed ID: 36580755
[TBL] [Abstract] [Full Text] [Related]
4. Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?
Mueller JJ; Rios-Doria E; Park KJ; Broach VA; Alektiar KM; Jewell EL; Zivanovic O; Sonoda Y; Abu-Rustum NR; Leitao MM; Gardner GJ
Gynecol Oncol; 2023 Jan; 168():1-7. PubMed ID: 36334496
[TBL] [Abstract] [Full Text] [Related]
5. Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification.
Zammarrelli WA; Kim SH; Da Cruz Paula A; Rios-Doria EV; Ehmann S; Yeoshoua E; Hanlon EJ; Zhou Q; Iasonos A; Alektiar KM; Aghajanian C; Makker V; Leitao MM; Abu-Rustum NR; Ellenson LH; Weigelt B; Mueller JJ
JCO Precis Oncol; 2022 Oct; 6():e2200194. PubMed ID: 36240474
[TBL] [Abstract] [Full Text] [Related]
6. Use and Accuracy of Intraoperative Frozen Section Analysis for ovarian Masses in Children and Adolescents.
Gil LA; Lutz CM; Dillon PA; Downard CD; Ehrlich PF; Fallat ME; Fraser JD; Grabowski JE; Helmrath MA; Hertweck SP; Hirschl RB; Kabre R; Lal DR; Landman MP; Lawrence AE; Leys CM; Mak GZ; Markel TA; Raiji MT; Rymeski B; Saito JM; Sato TT; St Peter SD; Stafford LMC; Deans KJ; Minneci PC; Hewitt GD; Aldrink JH;
J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):155-159. PubMed ID: 36209999
[TBL] [Abstract] [Full Text] [Related]
7. Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia.
Sait KH; Alam MZ; Haque A; Sait HK; Sait MK; Anfinan NM
Saudi Med J; 2022 Feb; 43(2):146-155. PubMed ID: 35110339
[TBL] [Abstract] [Full Text] [Related]
8. Past, Present, and Future of Serum Tumor Markers in Management of ovarian cancer: A Guide for the Radiologist.
Rao S; Smith DA; Guler E; Kikano EG; Rajdev MA; Yoest JM; Ramaiya NH; Tirumani SH
Radiographics; 2021 Oct; 41(6):1839-1856. PubMed ID: 34597221
[TBL] [Abstract] [Full Text] [Related]
9. Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
Safdar NS; Thompson EF; Gilks CB; Isacson C; Bennett JA; Clarke B; Young RH; Oliva E
Am J Surg Pathol; 2021 Aug; 45(8):1038-1046. PubMed ID: 34115671
[TBL] [Abstract] [Full Text] [Related]
10. Beyond Premature ovarian Insufficiency: staging Reproductive Aging in Adolescent and Young Adult cancer Survivors.
Medica ACO; Whitcomb BW; Shliakhsitsava K; Dietz AC; Pinson K; Lam C; Romero SAD; Sluss P; Sammel MD; Su HI
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1002-e1013. PubMed ID: 33141175
[TBL] [Abstract] [Full Text] [Related]
11. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
[TBL] [Abstract] [Full Text] [Related]
12. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
[TBL] [Abstract] [Full Text] [Related]
13. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult ovarian cancer and Surgeon Adherence to Recommended Practices.
Newcomb LK; Toal CT; Rindos NB; Wang L; Mansuria SM
J Minim Invasive Gynecol; 2020; 27(7):1511-1515. PubMed ID: 31927044
[TBL] [Abstract] [Full Text] [Related]
14. Impact of pre-operative walking on post-operative bowel function in patients with gynecologic cancer.
Özdemir İA; Comba C; Demirayak G; Gülseren V; Erdogan SV; Aslanova F; Afsar S; Gungorduk K
Int J Gynecol Cancer; 2019 Oct; 29(8):1311-1316. PubMed ID: 31326951
[TBL] [Abstract] [Full Text] [Related]
15. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract] [Full Text] [Related]
16. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
[TBL] [Abstract] [Full Text] [Related]
17. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Vergote I; Coens C; Nankivell M; Kristensen GB; Parmar MKB; Ehlen T; Jayson GC; Johnson N; Swart AM; Verheijen R; McCluggage WG; Perren T; Panici PB; Kenter G; Casado A; Mendiola C; Stuart G; Reed NS; Kehoe S; ;
Lancet Oncol; 2018 Dec; 19(12):1680-1687. PubMed ID: 30413383
[TBL] [Abstract] [Full Text] [Related]
18. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461
[TBL] [Abstract] [Full Text] [Related]
19. Endometriosis-associated ovarian cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
[TBL] [Abstract] [Full Text] [Related]
20. The FIGO Stage IVA Versus IVB of ovarian cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.
Tajik P; van de Vrie R; Zafarmand MH; Coens C; Buist MR; Vergote I; Bossuyt PMM; Kenter GG
Int J Gynecol Cancer; 2018 Mar; 28(3):453-458. PubMed ID: 29324537
[TBL] [Abstract] [Full Text] [Related]
[Next]
